These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35098667)

  • 21. The importance of treating by histological subtype in advanced soft tissue sarcoma.
    Martín Broto J; Le Cesne A; Reichardt P
    Future Oncol; 2017 Jan; 13(1s):23-31. PubMed ID: 27918201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.
    Gronchi A; Palmerini E; Quagliuolo V; Martin Broto J; Lopez Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz Beveridge R; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Braglia L; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    J Clin Oncol; 2020 Jul; 38(19):2178-2186. PubMed ID: 32421444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experience.
    Goy BW; Syed S; Padmanabhan A; Burchette RJ; Helmstedter CS
    Radiother Oncol; 2021 Dec; 165():174-178. PubMed ID: 34758339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
    Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT
    Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent.
    Dapper H; Diehl C; Knebel C; Mogler C; Borm K; Dobiasch S; Combs SE; Peeken JC
    Radiat Oncol; 2023 Mar; 18(1):44. PubMed ID: 36869396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients.
    Espat NJ; Bilsky M; Lewis JJ; Leung D; Brennan MF
    Cancer; 2002 May; 94(10):2706-11. PubMed ID: 12173340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
    Tawbi HA; Burgess M; Bolejack V; Van Tine BA; Schuetze SM; Hu J; D'Angelo S; Attia S; Riedel RF; Priebat DA; Movva S; Davis LE; Okuno SH; Reed DR; Crowley J; Butterfield LH; Salazar R; Rodriguez-Canales J; Lazar AJ; Wistuba II; Baker LH; Maki RG; Reinke D; Patel S
    Lancet Oncol; 2017 Nov; 18(11):1493-1501. PubMed ID: 28988646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma.
    Greto D; Saieva C; Loi M; Desideri I; Delli Paoli C; Lo Russo M; Pezzulla D; Teriaca MA; Lucidi S; Visani L; Terziani F; Olmetto E; Becherini C; Bonomo P; Francolini G; Campanacci DA; Scoccianti G; Livi L
    Am J Clin Oncol; 2019 Oct; 42(10):749-754. PubMed ID: 31503061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal Increase in Survival Throughout the Years in Patients with Soft Tissue Sarcoma with Synchronous Metastases: Results of a Population-Based Study.
    Vos M; Ho VKY; Oosten AW; Verhoef C; Sleijfer S
    Oncologist; 2019 Jul; 24(7):e526-e535. PubMed ID: 30190301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating soft tissue sarcomas with adjuvant chemotherapy.
    Patrikidou A; Domont J; Cioffi A; Le Cesne A
    Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.
    Nakamura T; Matsumine A; Kawai A; Araki N; Goto T; Yonemoto T; Sugiura H; Nishida Y; Hiraga H; Honoki K; Yasuda T; Boku S; Sudo A; Ueda T
    Cancer; 2016 May; 122(9):1408-16. PubMed ID: 26970174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
    Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
    Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study.
    Tian Z; Dong S; Yang Y; Gao S; Yang Y; Yang J; Zhang P; Wang X; Yao W
    BMC Cancer; 2022 Jan; 22(1):56. PubMed ID: 35022029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study.
    Nakamura T; Tsukushi S; Asanuma K; Katagiri H; Ikuta K; Nagano A; Kozawa E; Yamada S; Shido Y; Yamada K; Kawanami K; Ishimura D; Sudo A; Nishida Y
    Clin Exp Metastasis; 2019 Aug; 36(4):343-350. PubMed ID: 31209624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic Soft Tissue Sarcomas in Adolescents and Young Adults: A Specialist Center Experience.
    Younger E; Husson O; Asare B; Benson C; Judson I; Miah A; Zaidi S; Dunlop A; Al-Muderis O; van Houdt WJ; Jones RL; van der Graaf WTA
    J Adolesc Young Adult Oncol; 2020 Dec; 9(6):628-638. PubMed ID: 32379517
    [No Abstract]   [Full Text] [Related]  

  • 36. Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.
    Gronchi A; Stacchiotti S; Verderio P; Ferrari S; Martin Broto J; Lopez-Pousa A; Llombart-Bosch A; Dei Tos AP; Collini P; Jurado JC; De Paoli A; Donati DM; Poveda A; Quagliuolo V; Comandone A; Grignani G; Morosi C; Messina A; De Sanctis R; Bottelli S; Palassini E; Casali PG; Picci P
    Ann Oncol; 2016 Dec; 27(12):2283-2288. PubMed ID: 27733375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sarcoma brain metastases: Tertiary cancer center experience.
    Ababneh HS; Muhsen B; Fares AS; Hirbawi H; Awabdeh TA; Hussaini MA; Amarin R; Mousa AA; Salah S
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S758-S763. PubMed ID: 38384052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes.
    Kobayashi E; Naito Y; Asano N; Maejima A; Endo M; Takahashi S; Megumi Y; Kawai A
    Jpn J Clin Oncol; 2019 Oct; 49(10):938-946. PubMed ID: 31365116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan.
    Nakamura T; Asanuma K; Hagi T; Sudo A
    Drug Des Devel Ther; 2020; 14():4215-4220. PubMed ID: 33116409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation.
    Tanaka K; Kawano M; Iwasaki T; Itonaga I; Tsumura H
    BMC Cancer; 2019 Jan; 19(1):56. PubMed ID: 30634944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.